{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:29:19Z","timestamp":1793626159753,"version":"4.5.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Major Depressive Disorder (MDD) is a debilitating psychiatric disorder that is a leading cause of disability worldwide. Although treatment with antidepressants, such as Selective Serotonin Reuptake Inhibitors (SSRIs), has demonstrated clinical efficacy, the \u201ctrial and error\u201d approach in choosing the most effective antidepressant treatment for each patient allows for only a subset of patients to achieve response to the first line of treatment. Circular RNAs (circRNAs), are highly stable and brain-enriched non-coding RNAs that are mainly derived from the backsplicing and covalent joining of exons and introns of protein-coding genes. They are known to be important for brain development and function, cross the blood-brain-barrier, and be highly sensitive to changes in both synaptic activity and neuronal receptor signaling. Here we present evidence that expression of the brain-enriched circRNA, CDR1as, is associated with symptomatic response to SSRI treatment, and regulated by serotonin and Brain-Derived Neurotrophic Factor (BDNF) receptor activity. We present data using circRNA-specific PCR in baseline whole blood samples from two independent cohorts, drawn from the Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC) and the Biomarkers of ANTidepressant RESponse (ANTARES) clinical studies, showing that before treatment CDR1as is differentially expressed between future symptomatic responders and non-responders to treatment with the SSRI sertraline. Additional data from naturalistic antidepressant response studies further highlight the association between CDR1as and antidepressant effects of SSRIs as a class. In addition, we show that CDR1as levels are altered following sertraline treatment in responders with the trajectory of change post-treatment associated with long-term remission. Furthermore, we report that levels of CDR1as in the blood can specifically predict remission with SSRI treatment, but not response\/remission with Placebo or Bupropion treatments. Lastly, we provide evidence in animal mechanistic and neuronal culture studies, suggesting mouse Cdr1as is strongly regulated by 5-HT2A and BDNF receptor signaling. Taken together, our data identify a brain-enriched circRNA associated with known mechanisms of antidepressant response that can serve as a blood biomarker for predicting response and remission with SSRI treatment.<\/jats:p>","DOI":"10.1038\/s41380-026-03491-w","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:04:58Z","timestamp":1771355098000},"page":"3637-3652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A brain-enriched circRNA blood biomarker can predict response to SSRI antidepressants"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0309-0932","authenticated-orcid":false,"given":"Grigorios","family":"Papageorgiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3973-7862","authenticated-orcid":false,"given":"El Ch\u00e9rif","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gorgievski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Maxson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Lefrere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Julie","family":"Toupet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Courtet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Belzeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8579-4705","authenticated-orcid":false,"given":"Jane","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Carmody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy H.","family":"Perlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2983-1110","authenticated-orcid":false,"given":"Madhukar H.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni T.","family":"Tzavara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Mellios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"3491_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.amepre.2022.05.014","volume":"63","author":"RD Goodwin","year":"2022","unstructured":"Goodwin RD, Dierker LC, Wu M, Galea S, Hoven CW, Weinberger AH. Trends in U.S. depression prevalence from 2015 to 2020: The widening treatment gap. Am J Prev Med. 2022;63:726\u201333.","journal-title":"Am J Prev Med"},{"key":"3491_CR2","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","volume":"60","author":"BN Gaynes","year":"2009","unstructured":"Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv. 2009;60:1439\u201345.","journal-title":"Psychiatr Serv"},{"key":"3491_CR3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357\u201366.","journal-title":"Lancet"},{"key":"3491_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41386-023-01667-4","volume":"49","author":"MA Frye","year":"2024","unstructured":"Frye MA, Nemeroff CB. Pharmacogenomic testing for antidepressant treatment selection: Lessons learned and roadmap forward. Neuropsychopharmacology. 2024;49:282\u20134.","journal-title":"Neuropsychopharmacology"},{"key":"3491_CR5","doi-asserted-by":"publisher","first-page":"e1003777","DOI":"10.1371\/journal.pgen.1003777","volume":"9","author":"J Salzman","year":"2013","unstructured":"Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO. Cell-type specific features of circular RNA expression. PLoS Genet. 2013;9:e1003777.","journal-title":"PLoS Genet"},{"key":"3491_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333\u20138.","journal-title":"Nature"},{"issue":"2","key":"3491_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141\u201357.","journal-title":"RNA"},{"key":"3491_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nn.3975","volume":"18","author":"X You","year":"2015","unstructured":"You X, Vlatkovic I, Babic A, Will T, Epstein I, Tushev G, et al. Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity. Nat Neurosci. 2015;18:603\u201310.","journal-title":"Nat Neurosci"},{"key":"3491_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03274-1","volume":"20","author":"Z Wang","year":"2022","unstructured":"Wang Z, Yu R, Chen X, Bao H, Cao R, Li AN, et al. Clinical utility of cerebrospinal fluid-derived circular RNAs in lung adenocarcinoma patients with brain metastases. J Transl Med. 2022;20:74.","journal-title":"J Transl Med"},{"key":"3491_CR10","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","volume":"58","author":"A Rybak-Wolf","year":"2015","unstructured":"Rybak-Wolf A, Stottmeister C, Gla\u017ear P, Jens M, Pino N, Giusti S, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58:870\u201385.","journal-title":"Mol Cell"},{"key":"3491_CR11","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1111\/jcmm.17525","volume":"26","author":"G Wen","year":"2022","unstructured":"Wen G, Gu W. Circular RNAs in peripheral blood mononuclear cells are more stable than linear RNAs upon sample processing delay. J Cell Mol Med. 2022;26:5021\u201332.","journal-title":"J Cell Mol Med"},{"key":"3491_CR12","doi-asserted-by":"publisher","first-page":"e0141214","DOI":"10.1371\/journal.pone.0141214","volume":"10","author":"S Memczak","year":"2015","unstructured":"Memczak S, Papavasileiou P, Peters O, Rajewsky N. Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood. PLoS One. 2015;10:e0141214.","journal-title":"PLoS One"},{"key":"3491_CR13","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","volume":"185","author":"CX Liu","year":"2022","unstructured":"Liu CX, Chen LL. Circular RNAs: Characterization, cellular roles, and applications. Cell. 2022;185:2016\u201334.","journal-title":"Cell"},{"key":"3491_CR14","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41380-025-02925-1","volume":"30","author":"O Hatzimanolis","year":"2025","unstructured":"Hatzimanolis O, Sykes AM, Cristino AS. Circular RNAs in neurological conditions - computational identification, functional validation, and potential clinical applications. Mol Psychiatry. 2025;30:1652\u201375.","journal-title":"Mol Psychiatry"},{"key":"3491_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1176\/appi.neuropsych.20240086","volume":"37","author":"W Wylie","year":"2025","unstructured":"Wylie W, Mellios N, Bourgeois JA. Circular RNA and neuropsychiatric practice: A scoping review of the literature and discussion of unmet clinical needs. J Neuropsychiatry Clin Neurosci. 2025;37:313\u201325.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"3491_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110282","volume":"38","author":"AK Hafez","year":"2022","unstructured":"Hafez AK, Zimmerman AJ, Papageorgiou G, Chandrasekaran J, Amoah SK, Lin R, et al. A bidirectional competitive interaction between circHomer1 and Homer1b within the orbitofrontal cortex regulates reversal learning. Cell Rep. 2022;38:110282.","journal-title":"Cell Rep"},{"key":"3491_CR17","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1007\/s12035-023-03253-7","volume":"60","author":"S Seeler","year":"2023","unstructured":"Seeler S, Andersen MS, Sztanka-Toth T, Rybiczka-Te\u0161ulov M, van den Munkhof MH, Chang CC, et al. Circular RNA expressed from the FAT3 locus regulates neural development. Mol Neurobiol. 2023;60:3239\u201360.","journal-title":"Mol Neurobiol"},{"key":"3491_CR18","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.celrep.2020.01.083","volume":"30","author":"C Suenkel","year":"2020","unstructured":"Suenkel C, Cavalli D, Massalini S, Calegari F, Rajewsky N. A highly conserved circular RNA Is required to keep neural cells in a progenitor state in the mammalian brain. Cell Rep. 2020;30:2170\u20132179.e5.","journal-title":"Cell Rep"},{"key":"3491_CR19","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1038\/s41380-020-0653-4","volume":"25","author":"AJ Zimmerman","year":"2020","unstructured":"Zimmerman AJ, Hafez AK, Amoah SK, Rodriguez BA, Dell\u2019Orco M, Lozano E, et al. A psychiatric disease-related circular RNA controls synaptic gene expression and cognition. Mol Psychiatry. 2020;25:2712\u201327.","journal-title":"Mol Psychiatry"},{"key":"3491_CR20","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/s41593-019-0501-5","volume":"22","author":"U Dube","year":"2019","unstructured":"Dube U, Del-Aguila JL, Li Z, Budde JP, Jiang S, Hsu S, et al. An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations. Nat Neurosci. 2019;22:1903\u201312.","journal-title":"Nat Neurosci"},{"key":"3491_CR21","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1080\/15476286.2016.1255398","volume":"14","author":"M Hanan","year":"2017","unstructured":"Hanan M, Soreq H, Kadener S. CircRNAs in the brain. RNA Biol. 2017;14:1028\u201334.","journal-title":"RNA Biol"},{"key":"3491_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam8526","volume":"357","author":"M Piwecka","year":"2017","unstructured":"Piwecka M, Gla\u017ear P, Hernandez-Miranda LR, Memczak S, Wolf SA, Rybak-Wolf A, et al. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science. 2017;357:eaam8526.","journal-title":"Science"},{"key":"3491_CR23","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1038\/s41380-021-01303-x","volume":"26","author":"G Yoon","year":"2021","unstructured":"Yoon G, Lim YH, Jo D, Ryu J, Song J, Kim YK. Obesity-linked circular RNA circTshz2-2 regulates the neuronal cell cycle and spatial memory in the brain. Mol Psychiatry. 2021;26:6350\u201364.","journal-title":"Mol Psychiatry"},{"key":"3491_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jad.2020.05.109","volume":"274","author":"R Song","year":"2020","unstructured":"Song R, Bai Y, Li X, Zhu J, Zhang H, Shi Y, et al. Plasma circular RNA DYM related to major depressive disorder and rapid antidepressant effect treated by visual cortical repetitive transcranial magnetic stimulation. J Affect Disord. 2020;274:486\u201393.","journal-title":"J Affect Disord"},{"key":"3491_CR25","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/mds.28467","volume":"36","author":"S Ravanidis","year":"2021","unstructured":"Ravanidis S, Bougea A, Karampatsi D, Papagiannakis N, Maniati M, Stefanis L, et al. Differentially expressed circular RNAs in peripheral blood mononuclear cells of patients with Parkinson\u2019s disease. Mov Disord. 2021;36:1170\u20139.","journal-title":"Mov Disord"},{"key":"3491_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4103\/1673-5374.379017","volume":"19","author":"M Zhou","year":"2024","unstructured":"Zhou M, Li S, Huang C. Physiological and pathological functions of circular RNAs in the nervous system. Neural Regen Res. 2024;19:342\u20139.","journal-title":"Neural Regen Res"},{"key":"3491_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03743-3","volume":"12","author":"L Verduci","year":"2021","unstructured":"Verduci L, Tarcitano E, Strano S, Yarden Y, Blandino G. CircRNAs: role in human diseases and potential use as biomarkers. Cell Death Dis. 2021;12:468.","journal-title":"Cell Death Dis"},{"key":"3491_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110251","volume":"128","author":"Y Ma","year":"2020","unstructured":"Ma Y, Liu Y, Jiang Z. CircRNAs: A new perspective of biomarkers in the nervous system. Biomed Pharmacother. 2020;128:110251.","journal-title":"Biomed Pharmacother"},{"key":"3491_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40348-0","volume":"14","author":"X Dong","year":"2023","unstructured":"Dong X, Bai Y, Liao Z, Gritsch D, Liu X, Wang T, et al. Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease. Nat Commun. 2023;14:5327.","journal-title":"Nat Commun"},{"key":"3491_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384\u20138.","journal-title":"Nature"},{"key":"3491_CR31","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1038\/emboj.2011.359","volume":"30","author":"TB Hansen","year":"2011","unstructured":"Hansen TB, Wiklund ED, Bramsen JB, Villadsen SB, Statham AL, Clark SJ, et al. miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J. 2011;30:4414\u201322.","journal-title":"EMBO J"},{"key":"3491_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2023.107777","volume":"203","author":"EL Zajaczkowski","year":"2023","unstructured":"Zajaczkowski EL, Zhao Q, Liau WS, Gong H, Madugalle SU, Periyakaruppiah A, et al. Localised Cdr1as activity is required for fear extinction memory. Neurobiol Learn Mem. 2023;203:107777.","journal-title":"Neurobiol Learn Mem"},{"key":"3491_CR33","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1038\/s44319-024-00168-9","volume":"25","author":"CA Cerda-Jara","year":"2024","unstructured":"Cerda-Jara CA, Kim SJ, Thomas G, Farsi Z, Zolotarov G, Dube G, et al. miR-7 controls glutamatergic transmission and neuronal connectivity in a Cdr1as-dependent manner. EMBO Rep. 2024;25:3008\u201339.","journal-title":"EMBO Rep"},{"key":"3491_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jpsychires.2016.03.001","volume":"78","author":"MH Trivedi","year":"2016","unstructured":"Trivedi MH, McGrath PJ, Fava M, Parsey RV, Kurian BT, Phillips ML, et al. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design. J Psychiatr Res. 2016;78:11\u201323.","journal-title":"J Psychiatr Res"},{"key":"3491_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0022-3999(67)90010-4","volume":"11","author":"TH Holmes","year":"1967","unstructured":"Holmes TH, Rahe RH. The social readjustment rating scale. J Psychosom Res. 1967;11:213\u20138.","journal-title":"J Psychosom Res"},{"key":"3491_CR36","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22\u201333.","journal-title":"J Clin Psychiatry"},{"key":"3491_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.euroneuro.2017.12.015","volume":"28","author":"JL Consoloni","year":"2018","unstructured":"Consoloni JL, Ibrahim EC, Lefebvre MN, Zendjidjian X, Oli\u00e9 E, Mazzola-Pomietto P, et al. Serotonin transporter gene expression predicts the worsening of suicidal ideation and suicide attempts along a long-term follow-up of a Major Depressive Episode. Eur Neuropsychopharmacol. 2018;28:401\u201314.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3491_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.112","volume":"2","author":"R Belzeaux","year":"2012","unstructured":"Belzeaux R, Bergon A, Jeanjean V, Loriod B, Formisano-Tr\u00e9ziny C, Verrier L, et al. Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Transl Psychiatry. 2012;2:e185.","journal-title":"Transl Psychiatry"},{"key":"3491_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pnpbp.2011.12.005","volume":"38","author":"MA El Khoury","year":"2012","unstructured":"El Khoury MA, Gorgievski V, Moutsimilli L, Giros B, Tzavara ET. Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies. Prog Neuropsychopharmacol Biol Psychiatry. 2012;38:36\u201350.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3491_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.64719\/pb.4260","volume":"35","author":"HK Manji","year":"2001","unstructured":"Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull. 2001;35:5\u201349.","journal-title":"Psychopharmacol Bull"},{"key":"3491_CR41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22:238\u201349.","journal-title":"Nat Med"},{"key":"3491_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41386-022-01370-w","volume":"48","author":"LG Appelbaum","year":"2023","unstructured":"Appelbaum LG, Shenasa MA, Stolz L, Daskalakis Z. Synaptic plasticity and mental health: methods, challenges and opportunities. Neuropsychopharmacology. 2023;48:113\u201320.","journal-title":"Neuropsychopharmacology"},{"key":"3491_CR43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jad.2017.09.042","volume":"226","author":"S Leucht","year":"2018","unstructured":"Leucht S, Fennema H, Engel RR, Kaspers-Janssen M, Szegedi A. Translating the HAM-D into the MADRS and vice versa with equipercentile linking. J Affect Disord. 2018;226:326\u201331.","journal-title":"J Affect Disord"},{"key":"3491_CR44","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.cell.2018.05.022","volume":"174","author":"B Kleaveland","year":"2018","unstructured":"Kleaveland B, Shi CY, Stefano J, Bartel DP. A network of noncoding regulatory RNAs acts in the mammalian brain. Cell. 2018;174:350\u201362.","journal-title":"Cell"},{"key":"3491_CR45","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1242\/dev.080127","volume":"139","author":"S Kredo-Russo","year":"2012","unstructured":"Kredo-Russo S, Mandelbaum AD, Ness A, Alon I, Lennox KA, Behlke MA, et al. Pancreas-enriched miRNA refines endocrine cell differentiation. Development. 2012;139:3021\u201331.","journal-title":"Development"},{"key":"3491_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1841","volume":"15","author":"JH Yang","year":"2024","unstructured":"Yang JH, Tsitsipatis D, Gorospe M. Stoichiometry of long noncoding RNA interactions with other RNAs: Insights from OIP5-AS1. Wiley Interdiscip Rev RNA. 2024;15:e1841.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"3491_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0165-0327(03)00195-2","volume":"84","author":"J Angst","year":"2005","unstructured":"Angst J, Sellaro R, Stassen HH, Gamma A. Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord. 2005;84:149\u201357.","journal-title":"J Affect Disord"},{"key":"3491_CR48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/bdi.12513","volume":"19","author":"LV Kessing","year":"2017","unstructured":"Kessing LV, Willer I, Andersen PK, Bukh JD. Rate and predictors of conversion from unipolar to bipolar disorder: A systematic review and meta-analysis. Bipolar Disord. 2017;19:324\u201335.","journal-title":"Bipolar Disord"},{"key":"3491_CR49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.neuroscience.2009.03.080","volume":"164","author":"JH Barnett","year":"2009","unstructured":"Barnett JH, Smoller JW. The genetics of bipolar disorder. Neuroscience. 2009;164:331\u201343.","journal-title":"Neuroscience"},{"key":"3491_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.npp.1301571","volume":"33","author":"K Martinowich","year":"2008","unstructured":"Martinowich K, Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology. 2008;33:73\u201383.","journal-title":"Neuropsychopharmacology"},{"key":"3491_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijms23010010","volume":"23","author":"A Zi\u0119ba","year":"2021","unstructured":"Zi\u0119ba A, St\u0119pnicki P, Matosiuk D, Kaczor AA. Overcoming Depression with 5-HT2A Receptor Ligands. Int J Mol Sci. 2021;23:10.","journal-title":"Int J Mol Sci"},{"key":"3491_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","volume":"64","author":"BW Dunlop","year":"2007","unstructured":"Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007;64:327\u201337.","journal-title":"Arch Gen Psychiatry"},{"key":"3491_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109378","volume":"225","author":"S Lv","year":"2023","unstructured":"Lv S, Yao K, Zhang Y, Zhu S. NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research. Neuropharmacology. 2023;225:109378.","journal-title":"Neuropharmacology"},{"key":"3491_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuron.2019.12.011","volume":"105","author":"LE Potter","year":"2020","unstructured":"Potter LE, Zanos P, Gould TD. Antidepressant effects and mechanisms of group II mGlu receptor-specific negative allosteric Modulators. Neuron. 2020;105:1\u20133.","journal-title":"Neuron"},{"key":"3491_CR55","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.neuro.31.060407.125631","volume":"31","author":"SW Flavell","year":"2008","unstructured":"Flavell SW, Greenberg ME. Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu Rev Neurosci. 2008;31:563\u201390.","journal-title":"Annu Rev Neurosci"},{"key":"3491_CR56","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41591-018-0011-0","volume":"24","author":"K Apazoglou","year":"2018","unstructured":"Apazoglou K, Farley S, Gorgievski V, Belzeaux R, Lopez JP, Grenier J, et al. Antidepressive effects of targeting ELK-1 signal transduction. Nat Med. 2018;24:591\u20137.","journal-title":"Nat Med"},{"key":"3491_CR57","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1073\/pnas.052712799","volume":"99","author":"P Svenningsson","year":"2002","unstructured":"Svenningsson P, Tzavara ET, Witkin JM, Fienberg AA, Nomikos GG, Greengard P. Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proc Natl Acad Sci USA. 2002;99:3182\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3491_CR58","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41588-023-01596-4","volume":"56","author":"X Meng","year":"2024","unstructured":"Meng X, Navoly G, Giannakopoulou O, Levey DF, Koller D, Pathak GA, et al. Multi-ancestry genome-wide association study of major depression aids locus discovery, fine mapping, gene prioritization and causal inference. Nat Genet. 2024;56:222\u201333.","journal-title":"Nat Genet"},{"key":"3491_CR59","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41593-018-0326-7","volume":"22","author":"DM Howard","year":"2019","unstructured":"Howard DM, Adams MJ, Clarke TK, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22:343\u201352.","journal-title":"Nat Neurosci"},{"key":"3491_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40478-022-01326-7","volume":"10","author":"B Lee","year":"2022","unstructured":"Lee B, Mahmud I, Pokhrel R, Murad R, Yuan M, Stapleton S, et al. Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs. Acta Neuropathol Commun. 2022;10:25.","journal-title":"Acta Neuropathol Commun"},{"key":"3491_CR61","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/cr.2015.82","volume":"25","author":"Y Li","year":"2015","unstructured":"Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25:981\u20134.","journal-title":"Cell Res"},{"key":"3491_CR62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12987-022-00359-3","volume":"19","author":"HM Ramos-Zald\u00edvar","year":"2022","unstructured":"Ramos-Zald\u00edvar HM, Polakovicova I, Salas-Huenuleo E, Corval\u00e1n AH, Kogan MJ, Yefi CP, et al. Extracellular vesicles through the blood-brain barrier: a review. Fluids Barriers CNS. 2022;19:60.","journal-title":"Fluids Barriers CNS"},{"key":"3491_CR63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jad.2023.11.044","volume":"347","author":"A Szmulewicz","year":"2024","unstructured":"Szmulewicz A, Valerio MP, Lomastro J, Martino DJ. Melancholic features and treatment outcome to selective serotonin reuptake inhibitors in major depressive disorder: A re-analysis of the STAR*D trial. J Affect Disord. 2024;347:101\u20137.","journal-title":"J Affect Disord"},{"key":"3491_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110285","volume":"110","author":"M Dold","year":"2021","unstructured":"Dold M, Bartova L, Fugger G, Kautzky A, Mitschek MMM, Fabbri C, et al. Melancholic features in major depression - a European multicenter study. Prog Neuropsychopharmacol Biol Psychiatry. 2021;110:110285.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3491_CR65","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13578-020-00436-w","volume":"10","author":"J Zhao","year":"2020","unstructured":"Zhao J, Zhou Y, Guo M, Yue D, Chen C, Liang G, et al. MicroRNA-7: expression and function in brain physiological and pathological processes. Cell Biosci. 2020;10:77.","journal-title":"Cell Biosci"},{"key":"3491_CR66","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/0269881117725915","volume":"31","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris RL, Nutt DJ. Serotonin and brain function: A tale of two receptors. J Psychopharmacol. 2017;31:1091\u201320.","journal-title":"J Psychopharmacol"},{"key":"3491_CR67","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1126\/science.abb6748","volume":"388","author":"ZZ Ma","year":"2025","unstructured":"Ma ZZ, Guzikowski NJ, Kim JW, Kavalali ET, Monteggia LM. Enhanced ERK activity extends ketamine\u2019s antidepressant effects by augmenting synaptic plasticity. Science. 2025;388:646\u201355.","journal-title":"Science"},{"key":"3491_CR68","doi-asserted-by":"publisher","first-page":"13543","DOI":"10.3390\/ijms232113543","volume":"23","author":"EC Ibrahim","year":"2022","unstructured":"Ibrahim EC, Gorgievski V, Ortiz-Teba P, Belzeaux R, Turecki G, Sibille E, et al. Transcriptomic studies of antidepressant action in rodent models of depression: A first meta-analysis. Int J Mol Sci. 2022;23:13543.","journal-title":"Int J Mol Sci"}],"updated-by":[{"DOI":"10.1038\/s41380-026-03579-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000}}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03491-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03491-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03491-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:02:16Z","timestamp":1781510536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03491-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3491"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03491-w","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41380-026-03579-3","URL":"https:\/\/doi.org\/10.1038\/s41380-026-03579-3","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.P., G.M., R.B., R. P., E. G., M.H.T, E.T, and N.M. have financial interest in Circular Genomics Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}